Literature DB >> 8402620

Potential topoisomerase II DNA-binding sites at the breakpoints of a t(9;11) chromosome translocation in acute myeloid leukemia.

M Negrini1, C A Felix, C Martin, B J Lange, T Nakamura, E Canaani, C M Croce.   

Abstract

We have examined a t(9;11)(p22;q23) chromosome translocation in an acute myeloid leukemia of an infant. The breakpoints on the two chromosomes occurred within introns of the involved genes: AF-9 on chromosome 9, and ALL-1 on chromosome 11. Sequence analysis identified heptamers flanking the breakpoints on both chromosomes 9 and 11, suggesting that the V-D-J recombinase was involved in the translocation. The presence of an N-region between the two chromosomes supports the hypothesis that a mistake in V-D-J joining was involved in the genesis of the translocation and indicates that terminal deoxynucleotidyl transferase was expressed in the cells from which this acute myeloid leukemia originated. In addition, potential topoisomerase II DNA-binding sites were found near the breakpoints of both chromosomes, suggesting the involvement of altered topoisomerase II activity in this translocation. Altered topoisomerase II activity in the presence of an active V-D-J recombinase may be a pathogenetic mechanism of acute myeloid leukemia with rearrangements at 11q23.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8402620

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  The yeast SAS (something about silencing) protein complex contains a MYST-type putative acetyltransferase and functions with chromatin assembly factor ASF1.

Authors:  S Osada; A Sutton; N Muster; C E Brown; J R Yates; R Sternglanz; J L Workman
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

2.  Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias.

Authors:  Reiner Strick; Yanming Zhang; Neelmini Emmanuel; Pamela L Strissel
Journal:  Hum Genet       Date:  2006-03-30       Impact factor: 4.132

3.  Loss of drug-stimulated topoisomerase II DNA breaks in living cells is different at two unrelated loci.

Authors:  M Binaschi; M E Borgnetto; G Capranico
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

4.  Rapid high-resolution mapping of balanced chromosomal rearrangements on tiling CGH arrays.

Authors:  Harvey A Greisman; Noah G Hoffman; Hye Son Yi
Journal:  J Mol Diagn       Date:  2011-09-09       Impact factor: 5.568

5.  Cyclin E deregulation promotes loss of specific genomic regions.

Authors:  Leonardo K Teixeira; Xianlong Wang; Yongjiang Li; Susanna Ekholm-Reed; Xiaohua Wu; Pei Wang; Steven I Reed
Journal:  Curr Biol       Date:  2015-05-07       Impact factor: 10.834

6.  Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.

Authors:  Anna M Azarova; Yi Lisa Lyu; Chao-Po Lin; Yuan-Chin Tsai; Johnson Yiu-Nam Lau; James C Wang; Leroy F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

7.  Molecular analysis of lambda bio transducing phage produced by oxolinic acid-induced illegitimate recombination in vivo.

Authors:  H Shimizu; H Yamaguchi; H Ikeda
Journal:  Genetics       Date:  1995-07       Impact factor: 4.562

8.  Sequencing human-gibbon breakpoints of synteny reveals mosaic new insertions at rearrangement sites.

Authors:  Santhosh Girirajan; Lin Chen; Tina Graves; Tomas Marques-Bonet; Mario Ventura; Catrina Fronick; Lucinda Fulton; Mariano Rocchi; Robert S Fulton; Richard K Wilson; Elaine R Mardis; Evan E Eichler
Journal:  Genome Res       Date:  2008-11-24       Impact factor: 9.043

9.  Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites.

Authors:  C E Frantz; H Chen; D A Eastmond
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.